Kura Oncology Inc (KURA)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
957,216,000
EV to revenue ratio (TTM)
6.3
EV to ebitda
-2.479
Financial Performance
Revenue (TTM)
77,225,000
Gross profit (TTM)
-182,807,008
EBITDA
-316,799,008
Profitability
Operating margin (TTM)
-349.80%
Profit margin
0.00%
Return on assets (TTM)
-31.30%
Return on equity (TTM)
-167.70%
Per Share Metrics
Revenue per share (TTM)
0.88
EPS
-3.32
Diluted EPS (TTM)
-3.32
Book value
0.54
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
0
Price to sales ratio (TTM)
12.4
Price to book ratio (TTM)
20.26
Growth
Quarterly earnings growth (YoY)
36.50%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
12
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.434